Eva Schepers
Overview
Explore the profile of Eva Schepers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glorieux G, Vanholder R, Van Biesen W, Pletinck A, Schepers E, Neirynck N, et al.
Nephrol Dial Transplant
. 2021 Jan;
36(6):998-1005.
PMID: 33508125
Background: Several protein-bound uraemic toxins (PBUTs) have been associated with cardiovascular (CV) and all-cause mortality in chronic kidney disease (CKD) but the degree to which this is the case per...
2.
Verbeke F, Siwy J, Van Biesen W, Mischak H, Pletinck A, Schepers E, et al.
Nephrol Dial Transplant
. 2019 Dec;
36(5):811-818.
PMID: 31837226
Background: The urinary proteomic classifier chronic kidney disease 273 (CKD273) is predictive for the development and progression of chronic kidney disease (CKD) and/or albuminuria in type 2 diabetes. This study...
3.
Borges Bonan N, Schepers E, Pecoits-Filho R, Dhondt A, Pletinck A, De Somer F, et al.
Sci Rep
. 2019 Jul;
9(1):10236.
PMID: 31308443
Intermediate (CD14CD16) monocytes have important pro-inflammatory and atherogenic features and are increased in patients with chronic kidney disease (CKD). The present study aims to elucidate the role of the uremic...
4.
Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, et al.
Sci Rep
. 2019 Mar;
9(1):4477.
PMID: 30872798
Several microRNAs (miRNAs) have been linked to chronic kidney disease (CKD) mortality, cardiovascular (CV) complications and kidney disease progression. However, their association with clinical outcomes remains poorly evaluated. We used...
5.
Joossens M, Faust K, Gryp T, Nguyen A, Wang J, Eloot S, et al.
Gut
. 2018 Nov;
68(12):2257-2260.
PMID: 30464044
No abstract available.
6.
van Laecke S, Malfait T, Schepers E, Van Biesen W
Transpl Int
. 2018 Apr;
31(7):689-699.
PMID: 29611220
Cardiovascular disease (CVD) after transplantation remains a major concern. Little is known about what drives the increased cardiovascular risk in transplant recipients apart from traditional risk factors. The immune system...
7.
Gil R, Ortiz A, Sanchez-Nino M, Markoska K, Schepers E, Vanholder R, et al.
Nephrol Dial Transplant
. 2018 Mar;
33(12):2156-2164.
PMID: 29554320
Background: Chronic kidney disease (CKD) is a recognized global health problem. While some CKD patients remain stable after initial diagnosis, others can rapidly progress towards end-stage renal disease (ESRD). This...
8.
Vanholder R, Pletinck A, Schepers E, Glorieux G
Toxins (Basel)
. 2018 Jan;
10(1).
PMID: 29316724
In this narrative review, the biological/biochemical impact (toxicity) of a large array of known individual uremic retention solutes and groups of solutes is summarized. We classified these compounds along their...
9.
Schepers E, Glorieux G, Eloot S, Hulko M, Boschetti-de-Fierro A, Beck W, et al.
BMC Nephrol
. 2018 Jan;
19(1):1.
PMID: 29304774
Background: Membranes with increasing pore size are introduced to enhance removal of large uremic toxins with regular hemodialysis. These membranes might theoretically have higher permeability for bacterial degradation products. In...
10.
Pontillo C, Zhang Z, Schanstra J, Jacobs L, Zurbig P, Thijs L, et al.
Kidney Int Rep
. 2017 Nov;
2(6):1066-1075.
PMID: 29130072
Introduction: CKD273 is a urinary biomarker, which in advanced chronic kidney disease predicts further deterioration. We investigated whether CKD273 can also predict a decline of estimated glomerular filtration rate (eGFR)...